Pfizer, Apple, Palantir and Zebra Technologies Lead Premarket Stock Moves

According to CNBC, Pfizer traded near flat after reporting third-quarter earnings of 87 cents per share, excluding certain items, on revenue of $16.58 billion, topping analysts’ estimates of 73 cents per share and $15.87 billion. Apple shares fell nearly 4% after its fiscal fourth-quarter margin forecast disappointed and iPad sales missed estimates. Palantir Technologies dropped nearly 8% despite third-quarter earnings topping Wall Street’s estimates; U.S. commercial revenue rose 148% to $984 million, above U.S. government revenue of $953 million. The company projected about $2.65 billion in fourth-quarter revenue and $8.53 billion for full-year 2026. Zebra Technologies fell more than 6% despite better-than-expected third-quarter results, with adjusted earnings of $4.95 per share on revenue of $1.61 billion versus analysts’ estimates of $4.89 and $1.57 billion. Its free cash flow guidance of at least $1 billion for the year was slightly below the $1.02 billion estimate. Revvity gained 7% after raising its full-year pro forma adjusted earnings-per-share guidance to $5.40-$5.45 from $5.30-$5.40. Gartner slid more than 6% despite beating third-quarter expectations and issuing better-than-expected full-year earnings and revenue guidance. Yum Brands rose 1% after adjusted third-quarter earnings of $1.56 per share beat the $1.49 estimate; revenue of $2.05 billion was in line with consensus. The company said Taco Bell had rebounded following the cyclospora outbreak linked to iceberg lettuce at the chain.